Evoke Pharma (EVOK)
NASDAQ:EVOK
Holding EVOK?
Track your performance easily

Evoke Pharma (EVOK) Technical Analysis

445 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Evoke Pharma’s (EVOK) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting Evoke Pharma is a Sell.
Evoke Pharma’s (EVOK) 20-Day exponential moving average is 4.40, while Evoke Pharma’s (EVOK) share price is $4.44, making it a Sell.
Evoke Pharma’s (EVOK) 50-Day exponential moving average is 4.97, while Evoke Pharma’s (EVOK) share price is $4.44, making it a Sell.

Evoke Pharma (EVOK) Pivot Points

Sep 20, 2024, 04:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.95
4.04
4.20
4.30
4.45
4.55
4.71
Fibonacci
4.04
4.14
4.20
4.30
4.39
4.45
4.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evoke Pharma (EVOK) Moving Averages

Sep 20, 2024, 04:27 AM
Period
Simple
Exponential
MA5
4.26Sell
4.24Sell
MA10
4.13Buy
4.23Buy
MA20
4.27Sell
4.40Sell
MA50
5.22Sell
4.97Sell
MA100
5.59Sell
5.80Sell
MA200
7.42Sell
7.96Sell
Evoke Pharma’s (EVOK) 10-Day exponential moving average is 4.23, while Evoke Pharma’s (EVOK) share price is $4.44, making it a Buy.
Evoke Pharma’s (EVOK) 100-Day exponential moving average is 5.80, while Evoke Pharma’s (EVOK) share price is $4.44, making it a Sell.
Evoke Pharma’s (EVOK) stock price is $4.44 and Evoke Pharma’s (EVOK) 50-day simple moving average is 5.22, creating a Sell signal.
Evoke Pharma’s (EVOK) stock price is $4.44 and Evoke Pharma’s (EVOK) 100-day simple moving average is 5.59, creating a Sell signal.
Evoke Pharma’s (EVOK) stock price is $4.44 and Evoke Pharma’s (EVOK) 200-day simple moving average is 7.42, creating a Sell signal.

Evoke Pharma (EVOK) Technical Indicators

Sep 20, 2024, 04:27 AM
Name
Value
Implied Action
RSI (14)
42.63
Neutral
STOCH (9,6)
85.69
Sell
STOCHRSI (14)
72.69
Neutral
MACD (12,26)
-0.28
Sell
ADX (14)
18.90
Buy
Williams %R
-26.32
Buy
CCI (14)
7.18
Neutral
ATR (14)
0.45
-
Ultimate Oscillator
63.04
Neutral
ROC
-3.64
Sell
Evoke Pharma’s (EVOK) Relative Strength Index (RSI) is 42.63, creating a Neutral signal.
Evoke Pharma’s (EVOK) Trend Strength Indicator (ADX) is 18.90, creating a Buy signal.
Evoke Pharma’s (EVOK) Commodity Channel Index (CCI) is 7.18, creating a Neutral signal.
Evoke Pharma’s (EVOK) Price Rate of Change (ROC) is -3.64, creating a Sell signal.

FAQ

Is EVOK a Buy, Hold, or Sell?
Based on EVOK’s technical indicators, EVOK is a Sell.
    What is EVOK’s RSI (14)?
    EVOK’s RSI (14) is 42.63, which suggests EVOK is a Neutral.
      What is EVOK’s MACD?
      EVOK’s MACD is -0.28, which suggests EVOK is a Sell.
        What is EVOK’s 5-day moving average?
        EVOK’s 5-day moving average is 4.26, which suggests EVOK is a Sell.
          What is EVOK’s 20-day moving average?
          EVOK 20-day moving average is 4.27, which suggests EVOK is a Sell.
            What is EVOK’s 50-day moving average?
            EVOK’s 50-day moving average is 5.22, which suggests EVOK is a Sell.
              What is EVOK’s 200-day moving average?
              EVOK’s 200-day moving average is 7.42, which suggests EVOK is a Sell.
                What is EVOK’s Williams % R (14)?
                EVOK’s Williams % R (14) is -26.32, which suggests EVOK is a Buy.
                  What is EVOK’s CCI (14)?
                  EVOK’s CCI (14) is 7.18, which suggests EVOK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis